Post-migration follow-up of migrants identified to be at increased risk of developing tuberculosis at pre-migration screening: a systematic review and meta-analysis

The Lancet Infectious Diseases

Volumn 17, Issue 7, 2017, Pages 770-779

  Chan, Isaac H Y ^a,b   Kaushik, Nishta ^a,b   Dobler, Claudia C ^a,b,c  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; FOLLOW UP; HEALTH CARE POLICY; HIGH RISK POPULATION; HUMAN; INCIDENCE; INFECTION RATE; META ANALYSIS (TOPIC); MIGRANT; MIGRATION; PRIORITY JOURNAL; SCREENING; SYSTEMATIC REVIEW; TUBERCULOSIS; TUBERCULOSIS CONTROL; AUSTRALIA; RISK FACTOR;

AUSTRALIA; EMIGRATION AND IMMIGRATION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; RISK FACTORS; TRANSIENTS AND MIGRANTS; TUBERCULOSIS;

EID: 85017469105     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(17)30194-9     Document Type: Article

References (50)

1. WHO. The end TB strategy, 2014, World Health Organization, Geneva.
2. Lönnroth, K, Migliori, GB, Abubakar, I, et al. Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 45 (2015), 928–952.
3. Public Health England. Tuberculosis in the UK 2014 Report, 2014, Public Health England, London.
4. CDC. Trends in tuberculosis, 2014, 2015, Centers for Disease Control and Prevention, Atlanta.
5. ECDC/WHO Regional Office for Europe. Tuberculosis surveillance and monitoring in Europe 2016, 2016, European Centre for Disease Prevention and Control, Stockholm.
6. Dara, M, Gushulak, BD, Posey, DL, Zellweger, J-P, Migliori, GB, The history and evolution of immigration medical screening for tuberculosis. Expert Rev Anti Infect Ther 11 (2013), 137–146.
7. CDC. CDC immigration requirements: technical instructions for tuberculosis screening and treatment, 2009, Centers for Disease Control and Prevention, Atlanta, GA.
8. Communicable Diseases Network Australia. CDNA national guidelines for public health units—management of TB, 2015, Department of Health, Australia, Canberra.
9. Greenaway, CK, Schwartzman, K, Tuberculosis surveillance and screening in selective high-risk populations. Canadian Tuberculosis Standards, 7th edition, 2014, Canadian Lung Association, Public Health Agency of Canada, Ottawa, 321–344.
10. Public Health England. UK pre-entry tuberculosis screening report 2014, 2015, Public Health England, London.
11. Aldridge, RW, Yates, TA, Zenner, D, White, PJ, Abubakar, I, Hayward, AC, Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: a systematic review and meta-analysis. Lancet Infect Dis 14 (2014), 1240–1249.
12. Arshad, S, Bavan, L, Gajari, K, Paget, SNJ, Baussano, I, Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J 35 (2010), 1336–1345.
13. Liberati, A, Altman, DG, Tetzlaff, J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med, 6, 2009, e1000100.
14. Riley, RD, Higgins, JPT, Deeks, JJ, Interpretation of random effects meta-analyses. BMJ, 342, 2011, d549.
15. Higgins, JPT, Thompson, SG, Deeks, JJ, Altman, DG, Measuring inconsistency in meta-analyses. BMJ, 327, 2003, 557.
16. Fleiss, JL, Levin, B, Paik, MC, Statistical methods for rates and proportions, 2004, Wiley, Hoboken, NJ.
17. Vollset, SE, Confidence intervals for a binomial proportion. Stat Med 12 (1993), 809–824.
18. Wells, GA, Shea, B, D O'Connell, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses, 2000, The Ottawa Hospital Research Institute, Ottawa.
19. Orr, PH, Manfreda, J, Hershfield, ES, Tuberculosis surveillance in immigrants to Manitoba. CMAJ 142 (1990), 453–458.
20. Wang, JS, Allen, EA, Enarson, DA, Grzybowski, S, Tuberculosis in recent Asian immigrants to British Columbia, Canada: 1982–1985. Tubercle 72 (1991), 277–283.
21. Zuber, PL, Binkin, NJ, Ignacio, AC, et al. Tuberculosis screening for immigrants and refugees. Diagnostic outcomes in the state of Hawaii. Am J Respir Crit Care Med 154 (1996), 151–155.
22. DeRiemer, K, Chin, DP, Schecter, GF, Reingold, AL, Tuberculosis among immigrants and refugees. Arch Intern Med 158 (1998), 753–760.
23. MacIntyre, CR, Plant, AJ, Tuberculosis in South-East Asian refugees after resettlement—can prevention be improved by better policy and practice?. Prev Med 27 (1998), 815–820.
24. Dasgupta, K, Schwartzman, K, Marchand, R, Tennenbaum, TN, Brassard, P, Menzies, D, Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations. Am J Respir Crit Care Med 162 (2000), 2079–2086.
25. Pang, SC, Harrison, RH, Brearley, J, Jegathesan, V, Clayton, AS, Tuberculosis surveillance in immigrants through health undertakings in Western Australia. Int J Tuberc Lung Dis 4 (2000), 232–236.
26. LoBue, PA, Moser, KS, Screening of immigrants and refugees for pulmonary tuberculosis in San Diego County, California. Chest 126 (2004), 1777–1782.
27. Johnsen, NL, Steen, TW, Meyer, H, Heldal, E, Skarpaas, IJ, June, GB, Cohort analysis of asylum seekers in Oslo, Norway, 1987–1995: effectiveness of screening at entry and TB incidence in subsequent years. Int J Tuberc Lung Dis 9 (2005), 37–42.
28. Erkens, C, Slump, E, Kamphorst, M, et al. Coverage and yield of entry and follow-up screening for tuberculosis among new immigrants. Eur Respir J 32 (2008), 153–161.
29. Harstad, I, Heldal, E, Steinshamn, SL, Garasen, H, Jacobsen, GW, Tuberculosis screening and follow-up of asylum seekers in Norway: a cohort study. BMC Public Health, 9, 2009, 141.
30. Liu, Y, Weinberg, MS, Ortega, LS, Painter, JA, Maloney, SA, Overseas screening for tuberculosis in U.S.-bound immigrants and refugees. N Engl J Med 360 (2009), 2406–2415.
31. Lowenthal, P, Westenhouse, J, Moore, M, Posey, DL, Watt, JP, Flood, J, Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis 15 (2011), 761–766.
32. Mor, Z, Leventhal, A, Weiler-Ravell, D, Peled, N, Lerman, Y, Chest radiography validity in screening pulmonary tuberculosis in immigrants from a high-burden country. Respir Care 57 (2012), 1137–1144.
33. Gacek, P, Sosa, L, Lobato, MN, Assessment of postarrival tuberculosis examinations among immigrants and refugees screened overseas. Conn Med 77 (2013), 325–330.
34. Walter, ND, Painter, J, Parker, M, et al. Persistent latent tuberculosis reactivation risk in United States immigrants. Am J Respir Crit Care Med 189 (2014), 88–95.
35. Khan, K, Hirji, MM, Miniota, J, et al. Domestic impact of tuberculosis screening among new immigrants to Ontario, Canada. CMAJ 187 (2015), E473–E481.
36. Liu, Y, Posey, DL, Cetron, MS, Painter, JA, Effect of a culture-based screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: a population-based cross-sectional study. Ann Intern Med 162 (2015), 420–428.
37. Nuzzo, JB, Golub, JE, Chaulk, P, Shah, M, Postarrival tuberculosis screening of high-risk immigrants at a local health department. Am J Public Health 105 (2015), 1432–1438.
38. Aldridge, RW, Zenner, D, White, PJ, et al. Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519,955 migrants screened before entry to England, Wales, and Northern Ireland. Lancet 388 (2016), 2510–2518.
39. CDC. Reported tuberculosis in the United States, 2015, 2016, Centers for Disease Control and Prevention, Atlanta, GA.
40. Toms, C, Stapledon, R, Waring, J, Douglas, P, Tuberculosis notifications in Australia, 2012 and 2013. Commun Dis Intell Q Rep 39 (2015), E217–E235.
41. Public Health Agency of Canada. Tuberculosis in Canada 2014—pre-release, 2016, Public Health Agency of Canada, Ottawa, ON.
42. Fox, GJ, Barry, SE, Britton, WJ, Marks, GB, Contact investigation for tuberculosis: a systematic review and meta-analysis. Eur Respir J 41 (2013), 140–156.
43. Corbett, EL, Watt, CJ, Walker, N, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med 163 (2003), 1009–1021.
44. Dobler, CC, Biologic agents and tuberculosis. Microbiol Spectrum, 4, 2016 TNM17-0026-2016.
45. Torre-Cisneros, J, Doblas, A, Aguado, JM, et al. Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort. Clin Infect Dis 48 (2009), 1657–1665.
46. Dobler, CC, McDonald, SP, Marks, GB, Risk of tuberculosis in dialysis patients: a nationwide cohort study. PLoS One, 6, 2011, e29563.
47. Dobler, CC, Flack, JR, Marks, GB, Risk of tuberculosis among people with diabetes mellitus: an Australian nationwide cohort study. BMJ Open, 2, 2012, e000666.
48. Dara, M, Solovic, I, Sotgiu, G, et al. Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease: call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees. Eur Respir J 47 (2016), 1345–1347.
49. Getahun, H, Matteelli, A, Abubakar, I, et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 46 (2015), 1563–1576.
50. Nahid, P, Dorman, SE, Alipanah, N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis 63 (2016), e147–e195.